Sinovac Biotech LtdShs News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.01.24	Sinovac Board Rejects Partial Tender Offer By Alternative Liquidity Index - Quick Facts (RTTNews)
04.11.22	SINOVAC Biotech Receives WHO Prequalification For Varicella Vaccine (RTTNews)
11.10.22	SVA FINAL DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Glob... (PR Newswire)
05.10.22	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LL... (PR Newswire)
01.10.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Cert... (PR Newswire)
23.09.22	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain... (PR Newswire)
14.09.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Cert... (PR Newswire)
07.09.22	ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain o... (PR Newswire)
30.08.22	ROSEN, A LEADING LAW FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA (PR Newswire)
19.08.22	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certa... (PR Newswire)
14.07.22	Sinovac: Anvisa Approves CoronaVac For Emergency Use In Children Aged 3-5 Years (RTTNews)
25.06.22	China's Sinovac COVID-19 Vaccine CoronaVac Registered For Use In South Africa (RTTNews)
09.11.21	SINOVAC Reports Positive Phase-3 Data On CoronaVac In Petiatric, Adolescent Population (RTTNews)
08.09.21	Sinovac Biotech Announces Approval Of CoronaVac For Children In Chile (RTTNews)
09.08.21	INOVIO Expands Partnership With Advaccine To Explore Heterologous Prime-boosting Using INO-4800 (RTTNews)
19.07.21	China Approves SINOVAC's Sabin Strain Based Inactivated Polio Vaccine (RTTNews)
12.07.21	SINOVAC In Deal With Gavi To Supply 380 Mln Doses Of CoronaVac Through COVAX (RTTNews)
02.06.21	WHO Authorizes Sinovac's CoronaVac For Emergency Use - Quick Facts (RTTNews)
08.02.21	China Grants Conditional Marketing Authorization To Sinovac's COVID-19 Vaccine (RTTNews)
03.02.21	Sinovac Biotech Files For Conditional Market Authorization Of COVID-19 Vaccine In China (RTTNews)
09.12.20	Sinovac: China NMPA Issues Product License For 23-Valent Pneumococcal Polysaccharide Vaccine (RTTNews)
07.12.20	Sinovac Secures $500 Mln In Funding To Develop COVID-19 Vaccine Candidate CoronaVac (RTTNews)
22.09.20	Sinovac Begins Phase III Clinical Trials For COVID-19 Vaccine Candidate In Turkey (RTTNews)
13.06.20	Race For COVID-19 Vaccine: Who Are The Key Players? (RTTNews)
18.05.20	SEC Finds Activist Investor Li Didn't Disclose Key Facts On Holdings Of Sinovac (RTTNews)
17.04.20	Sinovac Begins Phase I Human Trial For COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
16.04.20	Dynavax, Sinovac Collaborate To Develop COVID-19 Vaccine - Quick Facts (RTTNews)
17.09.18	Sinovac: DOJ Closes Its Investigation - Quick Facts (RTTNews)
20.08.18	Sinovac Biotech Says SEC Concludes Investigation - Quick Facts (RTTNews)
11.06.18	Sinovac Biotech Relaunches Company Website (PR Newswire)
11.05.18	Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results (PR Newswire)
08.05.18	Sinovac Forced to Temporarily Suspend Hepatitis A Vaccine Production Line Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing (PR Newswire)
01.05.18	Sinovac Biotech Says Forced To Temporarily Suspend Flu Vaccine Production (RTTNews)
01.05.18	Sinovac Forced to Temporarily Suspend Flu Vaccine Production Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing (PR Newswire)
30.04.18	Sinovac Forced to Plan to Destroy Bacterial Seeds intended for Pneumo Vaccine Production and Postpone Site Inspection (PR Newswire)
30.04.18	Sinovac Temporarily Blocks Access to Its Websites (PR Newswire)
27.04.18	Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing (PR Newswire)
27.04.18	Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction (PR Newswire)
23.04.18	Sinovac Resumes Production and Operation at Sinovac Beijing's Quality Assurance Department (PR Newswire)
19.04.18	Sinovac Announces Preliminary Results of Phase III Trial on sIPV (PR Newswire)
18.04.18	Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd. (PR Newswire)
27.03.18	Sinovac Biotech Amends Going-Private Deal; Termination Date Extended To April 26 (RTTNews)
27.03.18	Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction (PR Newswire)
15.03.18	Sinovac Sets the Record Straight Regarding False Statements by Unauthorized Third Parties (PR Newswire)
14.03.18	Sinovac Newly-Elected Board of Directors' Response to the Announcement of the Purported Re-Election of All Directors at the February 6, 2018 Annual General Meeting (PR Newswire)
06.03.18	Sinovac Amends Shareholder Rights Plan (PR Newswire)
06.03.18	Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity (PR Newswire)
07.02.18	Sinovac Provides Update on Going Private Transaction (PR Newswire)
07.02.18	Sinovac Holds 2017 Annual General Meeting of Shareholders (PR Newswire)
29.12.17	Sinovac Schedules 2017 Annual Meeting of Shareholders (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Handel in Europa: STOXX 50 schliesst im Minus
20.12.24		Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		NASDAQ-Handel NASDAQ 100 schwächelt zum Start des Freitagshandels
20.12.24		Anleger in London halten sich zurück: So bewegt sich der FTSE 100 aktuell
20.12.24		Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer
20.12.24		Börse Frankfurt: DAX präsentiert sich nachmittags leichter
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

NASDAQ-Handel NASDAQ 100 schwächelt zum Start des Freitagshandels

20.12.24

Anleger in London halten sich zurück: So bewegt sich der FTSE 100 aktuell

20.12.24

Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer